Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycleDAELEMANS, Dirk; DUMONT, Jean-Maurice; ROSENWIRTH, Brigitte et al.Antiviral research. 2010, Vol 85, Num 2, pp 418-421, issn 0166-3542, 4 p.Article

Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesROSENWIRTH, Brigitte; KUHN, Eva-Maria; HEENEY, Jonathan L et al.Vaccine. 2001, Vol 19, Num 13-14, pp 1661-1670, issn 0264-410XConference Paper

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding AgentPTAK, Roger G; GALLAY, Philippe A; DUMONT, Jean-Maurice et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1302-1317, issn 0066-4804, 16 p.Article

Readily acquired secondary infections of human and simian immunodeficiency viruses following single intravenous exposure in non-human primatesTEN HAAFT, Peter; VERSCHOOR, Ernst J; VERSTREPEN, Babs et al.Journal of general virology. 2004, Vol 85, pp 3735-3745, issn 0022-1317, 11 p., 12Article